The announcement of a new partnership was the plant food growing FMC's (FMC 5.05%) stock price during Wednesday's trading session. The agricultural sciences company's shares advanced to close the day more than 5% higher, a percentage rate that trounced the essentially flat performance of the benchmark S&P 500 (^GSPC 0.01%). Collaborating with Corteva Just after market close on Tuesday, FMC announced that it has signed a "strategic agreement" with agribusiness peer Corteva Agriscience (CTVA 0.27%). According ...

Key Takeaways FMC partners with Corteva to expand use of fluindapyr fungicide in U.S. corn and soybean markets. The deal promotes fluindapyr-based products to tackle tough foliar diseases like tar spot and rust. Corteva plans to launch its fluindapyr product in 2026, pending EPA regulatory approval.FMC Corporation (FMC) has entered into a strategic partnership with Corteva Agriscience to broaden the use of its fluindapyr fungicide technology in the U.S. corn and soybean markets. This collaboration aims to ...

PHILADELPHIA, June 3, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced a strategic agreement with Corteva Agriscience that will expand FMC's fluindapyr fungicide technology in the U.S. corn and soybean markets. The collaboration between the two agricultural companies will enable more U.S. growers to combat challenging foliar diseases, such as tar spot and southern rust, with this novel fungicide active ingredient.Under the terms of the agreeme ...

FMC Corporation (NYSE: FMC ) is a global agricultural giant that provides innovative and sustainable crop protection solutions. It traces its history back to 1883, when it initially developed a pump for spraying insecticides. Since, the company has drastically evolved, entering many businessesAs a detail-oriented investor with a strong foundation in finance and business writing, I focus on analyzing undervalued and disliked companies or industries that have strong fundamentals and good cash flows. I have a ...

PHILADELPHIA, May 21, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today released its 2024 sustainability report, Innovation for Agriculture. Solutions for the Planet. In its 14th annual report, the company demonstrates how integrating sustainability across business and functional strategies continues to drive value and growth for both the company and its stakeholders. "Sustainability is not only an environmental imperative, but also a business strategy," ...

Company Overview - FMC Corporation is an agricultural science company that specializes in insecticides, herbicides, and crop nutrition [1] - The company also produces pest control products and turf solutions for non-agricultural markets, such as golf courses [1] - FMC employs approximately 5,700 people [1] Industry Focus - The company operates within the agricultural sector, focusing on crop protection and nutrition [1] - FMC's product offerings cater to both agricultural and non-agricultural markets, indicating a diversified approach to its business model [1]

FMC (FMC) Conference May 15, 2025 09:30 AM ET Speaker0 We will do our next session here. It's with FMC, of course, pure play crop protection chemicals producer. Happy to have with us today the CFO, Andrew Sandifer and Pierre Brondeau, CEO. We had a nice dinner last night with a lot of investors. So we're going to pick up the conversation today. If you want to ask any questions, again, submit on the app. Maybe Pierre, Andrew, we could start off by you've labeled this as kind of a reset year or the first half ...

Have you evaluated the performance of FMC's (FMC) international operations during the quarter that concluded in March 2025? Considering the extensive worldwide presence of this chemical producer, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.In today's increasingly interconnected global economy, a company's ability to tap into international markets can be a pivotal factor in shaping its overall financial health and growth traj ...

Revenue and Sales Performance - Revenue for Q1 2025 was $791.4 million, a decrease of $126.6 million or approximately 14% compared to the prior year, primarily due to pricing declines and lower volumes in all regions except Latin America [204]. - Sales in North America decreased by approximately 28%, while Latin America saw an increase of approximately 10% in Q1 2025 [204]. - Organic revenue change for Q1 2025 was a decline of 10% after accounting for foreign currency impacts [213]. - Revenue for the three months ended March 31, 2025, was $791.4 million, a decrease of $126.6 million or approximately 14% compared to the prior year, primarily due to a 9% price decline and lower volumes in all regions except Latin America [218]. Profitability and Earnings - Gross margin for Q1 2025 was $316.7 million, down $23.0 million from the prior year, but gross margin as a percentage of revenue improved to approximately 40% from 37% in the prior year due to lower raw material costs [204]. - Adjusted after-tax earnings from continuing operations for Q1 2025 were $22.4 million, a decrease of approximately 51% from $45.4 million in the prior year [204]. - Adjusted EBITDA for the three months ended March 31, 2025, was $119.7 million, a decrease of $40.9 million or approximately 25% year-over-year, impacted by unfavorable pricing and reduced volumes [241]. - The net loss for the three months ended March 31, 2025, was $15.6 million, compared to a net loss of $3.1 million in the prior year, influenced by lower sales and increased expenses [238]. Expenses and Cost Management - Selling, general and administrative expenses increased by approximately 5% to $172.0 million in Q1 2025, while research and development expenses rose by 13% to $68.7 million [204]. - Selling, general and administrative expenses increased by $8.1 million or 5% to $172.0 million, primarily due to investments in new products and an expanded sales force in Brazil [225]. - Research and development expenses rose by $7.8 million or 13% to $68.7 million, reflecting increased spending on project expenses [226]. - Restructuring charges for the three months ended March 31, 2025, totaled $13.6 million, down from $33.7 million in the prior year, as part of the Project Focus initiative [229]. Debt and Cash Flow - Total debt as of March 31, 2025, was $4,003.5 million, down from $4,335.7 million in the prior year [216]. - Cash provided by operating activities of continuing operations was $(545.0) million for the three months ended March 31, 2025, compared to $(142.9) million for the same period in 2024 [251]. - Free cash flow for the three months ended March 31, 2025, was $(595.7) million, significantly lower than $(187.8) million in 2024, primarily due to increased capital expenditures and working capital needs [267]. - Total debt increased to $4,003.5 million as of March 31, 2025, compared to $3,365.3 million at December 31, 2024, with long-term debt remaining relatively stable [246]. Future Projections - The company expects 2025 revenue to be in the range of approximately $4.15 billion to $4.35 billion, essentially flat at the midpoint versus 2024, with a projected increase of 3% excluding the impact of divestitures [205]. - Adjusted EBITDA for 2025 is expected to be between $870 million and $950 million, reflecting a 1% increase at the midpoint compared to 2024 results [205]. - The company expects 2025 free cash flow to range between $200 million and $400 million, reflecting a normalization of working capital after a correction in 2024 [274]. - The company expects to incur approximately $375 million to $425 million in pre-tax restructuring charges over the life of the program, including $90 million to $100 million in non-cash asset write-off charges [279]. Capital Expenditures and Investments - Projected capital expenditures for 2025 are expected to be in the range of approximately $105 million to $115 million, primarily driven by investments in new products [280]. - The company achieved $165 million in cost benefits in 2024, with a targeted annual run-rate savings of more than $225 million by the end of 2025 [279]. Liquidity and Financial Position - The remaining borrowing capacity under the credit facility was $1,095.1 million as of March 31, 2025, providing adequate liquidity to meet debt obligations [248]. - The average effective interest rate on commercial paper borrowings was 5.1% as of March 31, 2025, with outstanding commercial paper increasing to $694.8 million [248]. - The company remains in compliance with all debt covenants and is committed to maintaining solid investment-grade credit metrics [247]. Shareholder Returns - The company paid dividends of $72.7 million and $72.5 million during the three months ended March 31, 2025, and March 31, 2024, respectively, and expects to continue quarterly dividend payments [282]. - The company does not anticipate any share repurchases during 2025, except for purchases associated with equity compensation plans [281].

FMC Corporation (NYSE:FMC) Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ET Company Participants Curt Brooks - Director of IR Pierre Brondeau - Chairman and CEO Andrew Sandifer - EVP and CFO Ronaldo Pereira - President Conference Call Participants Aleksey Yefremov - KeyBanc Joel Jackson - BMO Capital Edgar Rodriguez - Mizuho Daniel Rizzo - Jefferies Chris Parkinson - Wolfe Research Benjamin Theurer - Barclays Patrick Cunningham - Citigroup Vincent Andrews - Morgan Stanley Lucas Beaumont - UBS Frank M ...